Maranhão, Raul Cavalcante 
; Vital, Carolina Graziani; Tavani, Thauany Martins; Graziani, Silvia Regina
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: QUIMIOTERAPIA, NEOPLASIAS, LIPOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents. Expert Opinion on Drug Delivery, v. 14, n. 10, p. 1217-1226, 2017Tradução . . Disponível em: https://doi.org/10.1080/17425247.2017.1276560. Acesso em: 19 maio 2024.APA
Maranhão, R. C., Vital, C. G., Tavani, T. M., & Graziani, S. R. (2017). Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents. Expert Opinion on Drug Delivery, 14( 10), 1217-1226. doi:10.1080/17425247.2017.1276560NLM
Maranhão RC, Vital CG, Tavani TM, Graziani SR. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents [Internet]. Expert Opinion on Drug Delivery. 2017 ; 14( 10): 1217-1226.[citado 2024 maio 19 ] Available from: https://doi.org/10.1080/17425247.2017.1276560Vancouver
Maranhão RC, Vital CG, Tavani TM, Graziani SR. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents [Internet]. Expert Opinion on Drug Delivery. 2017 ; 14( 10): 1217-1226.[citado 2024 maio 19 ] Available from: https://doi.org/10.1080/17425247.2017.1276560
